[Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer]. [PDF]
Guo H, Bai R, Cui J.
europepmc +1 more source
[Progress and prospects of clinical cell therapy for liver cirrhosis and liver cancer]. [PDF]
Liu K, Wang LF, Wang FS, Shi M.
europepmc +1 more source
[Biological characteristics and antitumor activity of CIK cells activated by recombinant human fibronectin for human lung cancer cell lines in vitro]. [PDF]
Wang S +9 more
europepmc +1 more source
[Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. [PDF]
Department of Medical Administration +1 more
europepmc +1 more source
[Antitumor Study of Neoantigen-reactive T Cells Co-expressing IL-7 and CCL19 in Mouse Lung Cancer]. [PDF]
Wu D +7 more
europepmc +1 more source
[Mechanism of NKG2D ligands-mediated immune escape of adriamycin resistant leukemia K562/A02 cells]. [PDF]
Jia ZX +8 more
europepmc +1 more source
[New Progress in the Relationship between Immune Cells, PD-1 in Tumor Microenvironment and the Efficacy of EGFR-TKIs]. [PDF]
Yuan S, Xu H, Xie J.
europepmc +1 more source
[Advances in application of adoptive T-cell therapy for cancer patients]. [PDF]
Jixia Z, Chengyan Z, Pingli W.
europepmc +1 more source
[Efficacy and peripheral immunity analysis of allogeneic natural killer cells therapy in patients with hepatocellular carcinoma]. [PDF]
Xie YB +14 more
europepmc +1 more source
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis [PDF]
core +2 more sources

